Search

everythinglearnresearchcommunity

for

Search:↓

Betulin oil doesn't stop hair loss or help regrow hair in hypothyroidism.

Patients with thyroid disorders show different symptoms and antibody levels.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

EPDS and MS might share an immune-related cause.

A rare case of a man having both frontal fibrosing alopecia and vitiligo was reported.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Thyroid function may influence hair loss after COVID-19.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Thyroid disorders are common and affect health and quality of life, especially in women, highlighting the need for more awareness and iodine intake.

Low vitamin D3 is not linked to different levels of thyroid hormones in people with autoimmune thyroid disease.

Blocking interferon-gamma might help treat various autoimmune diseases.

Erianin may effectively treat alopecia areata by targeting the immune system.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

More research is needed to understand alopecia areata severity.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.